Wells Fargo & Company Endra Life Sciences Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $319.0 $6 - $9,570	30 Added 2.06%	1,489 $0
Q2 2022 Aug 12, 2022	BUY	$0.19 - $0.45 $28 - $67	150 Added 11.46%	1,459 $0
Q1 2022 May 16, 2022	BUY	$0.36 - $0.77 $1 - $2	3 Added 0.23%	1,309 $0
Q4 2021 Feb 14, 2022	BUY	$0.69 - $1.73 $0 - $1	1 Added 0.08%	1,306 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.38 - $2.15 $2 - $4	2 Added 0.15%	1,305 $2,000
Q2 2021 Aug 16, 2021	BUY	$1.98 - $2.74 $41 - $57	21 Added 1.64%	1,303 $3,000
Q1 2021 May 13, 2021	BUY	$0.8 - $2.85 $56 - $199	70 Added 5.78%	1,282 $4,000
Q4 2020 Feb 09, 2021	BUY	$0.69 - $0.9 $20 - $27	30 Added 2.54%	1,212 $1,000
Q3 2020 Nov 05, 2020	BUY	$0.72 - $1.04 $39 - $57	55 Added 4.88%	1,182 $1,000
Q2 2020 Aug 13, 2020	BUY	$0.63 - $1.1 $0 - $1	1 Added 0.09%	1,127 $1,000
Q1 2020 May 14, 2020	BUY	$0.68 - $2.14 $765 - $2,409	1,126 New	1,126 $1,000

Ticker NDRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 63,174,500
Market Cap $398M
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.